Press release 2011-04-19
Overwhelming response to the expanded C-RAD product range presented at the ESTRO meeting in London, UK
C-RAD AB with its three fully owned subsidiaries are all active in the field of radiation therapy. The company attended the European oncology and physicist meeting ESTRO in London, UK, 8-12 May 2011. The Catalyst™ system was presented for the first time, along with the already established Sentinel™ and GEMini™ products.
The annual ESTRO meeting is the largest recurring event in Europe where companies in the radiation therapy market meet with end customers and partners. At this year’s event, the C-RAD booth was centrally located close to all the major LINAC vendors.
The new Catalyst™ system, with its unique features for real-time verification and visual guidance, drew a lot of attention and was constantly demonstrated during the show’s opening hours to end customers as well as vendors. There was also a continued high interest for the Sentinel™ and GEMini™ systems. Many new leads were identified, and discussions with industrial partners were held for all the products in the C-RAD product range.
Parallel to the technical exhibition, the university clinics were publishing their newest findings. The university hospital in Lund detailed their clinical use of the Sentinel™ system, which has proven to result in an increase in patient throughput by 50% with a significant reduction in non-prescribed dose to healthy tissue. The university hospital in Uppsala presented their results on the clinical accuracy of the Sentinel™ system.
The Paracelsus Medical University in Salzburg reported their initial findings on comparing the GEMini™ ED detector to a conventional amorphous silicon detector, confirming the superior speed of the GEMini™ detector.
Erik Hedlund, CEO, C-RAD AB:
"The overwhelming response received at this year’s ESTRO meeting again confirms the demand for the C-RAD product range in the radiation therapy market. The official launch of the Catalyst™ system generated tremendous interest. Negotiations for further orders are being finalized."
